Strategic Initiative
Slingshot members are tracking this corporate initiative:
Editas Medicine (EDIT) enters agreement with Sandhill Therapeutics to develop allogeneic engineered natural killer (NK) cells and non-alpha beta T cell medicines for the treatment of cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EDIT |
|
|
||||
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jan 13, 2020 Projected Implementation: Q1, 2020 Relevance Tracked Until: Q2, 2020
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Nk Cells, T Cell, Cancer Treatment, Allogenic T-cell Therapies
